User profiles for Gerard Espinosa
 | Gerard EspinosaServei de Malalties Autoimmunes, Hospital Clinic, Barcelona Verified email at clinic.cat Cited by 20486 |
Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients
…, R Cervera, JC Piette, Y Shoenfeld, G Espinosa… - Medicine, 2001 - journals.lww.com
The antiphospholipid syndrome (APS), originally defined as the combination of venous or
arterial thrombotic events, recurrent fetal loss, and, frequently, a moderate thrombocytopenia …
arterial thrombotic events, recurrent fetal loss, and, frequently, a moderate thrombocytopenia …
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients
…, A Fernandez-Nebro, JC Piette, G Espinosa… - Annals of the …, 2009 - ard.bmj.com
Objectives: To identify the main causes of morbidity and mortality in patients with antiphospholipid
syndrome (APS) during a 5-year period and to determine clinical and immunological …
syndrome (APS) during a 5-year period and to determine clinical and immunological …
Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients
S Bucciarelli, G Espinosa, R Cervera… - … : Official Journal of …, 2006 - Wiley Online Library
Objective To assess the main causes of death and the prognostic factors that influence
mortality in patients with the catastrophic antiphospholipid syndrome (CAPS). Methods We …
mortality in patients with the catastrophic antiphospholipid syndrome (CAPS). Methods We …
Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults
J Font, R Cervera, G Espinosa, L Pallarés… - Annals of the …, 1998 - ard.bmj.com
OBJECTIVE To define the pattern of disease expression in patients with childhood onset
systemic lupus erythematosus (SLE). METHODS Prospective analysis of clinical manifestations …
systemic lupus erythematosus (SLE). METHODS Prospective analysis of clinical manifestations …
Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome
…, J Font, JA Gómez-Puerta, G Espinosa… - Annals of the …, 2005 - ard.bmj.com
Objective: To describe the characteristics of patients with catastrophic antiphospholipid
syndrome (APS) included in the International Registry of patients with this condition (CAPS …
syndrome (APS) included in the International Registry of patients with this condition (CAPS …
Treatment of antineutrophil cytoplasmic antibody–associated vasculitis: a systematic review
X Bosch, A Guilabert, G Espinosa, E Mirapeix - Jama, 2007 - jamanetwork.com
ContextImmunosuppressive therapies for antineutrophil cytoplasmic antibody (ANCA)–associated
vasculitis have greatly advanced patient survival but have turned ANCA-associated …
vasculitis have greatly advanced patient survival but have turned ANCA-associated …
Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the International CAPS Registry
Objective To analyze the clinical and immunologic manifestations of patients with catastrophic
antiphospholipid syndrome (CAPS) from the “CAPS Registry”. Methods The demographic, …
antiphospholipid syndrome (CAPS) from the “CAPS Registry”. Methods The demographic, …
[PDF][PDF] Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis
…, L Martínez, V Fonollosa, G Espinosa… - The American Journal of …, 2014 - cell.com
In this study, 1,833 systemic sclerosis (SSc) cases and 3,466 controls were genotyped with
the Immunochip array. Classical alleles, amino acid residues, and SNPs across the human …
the Immunochip array. Classical alleles, amino acid residues, and SNPs across the human …
Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab
The catastrophic variant of the antiphospholipid syndrome (APS) is characterized by
thrombosis in multiple organs developing over a short period of time. First-line treatment for the …
thrombosis in multiple organs developing over a short period of time. First-line treatment for the …
Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients
G Espinosa, E Santos, R Cervera, JC Piette… - Medicine, 2003 - journals.lww.com
To describe the clinical and immunologic characteristics of patients with adrenal
involvement and antiphospholipid syndrome (APS), we conducted a computer-assisted (PubMed) …
involvement and antiphospholipid syndrome (APS), we conducted a computer-assisted (PubMed) …